These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15126656)

  • 41. CT volumetric assessment of pulmonary neoplasms after radiofrequency ablation: when to consider a second intervention?
    Nour-Eldin NE; Naguib NN; Tawfik AM; Gruber-Rouh T; Zangos S; Vogl TJ
    J Vasc Interv Radiol; 2014 Mar; 25(3):347-54. PubMed ID: 24581459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and Clinical Outcomes of Percutaneous Radiofrequency Ablation for Intermediate and Large Bone Tumors Using a Multiple-Electrode Switching System: A Phase II Clinical Study.
    Nakatsuka A; Yamakado K; Uraki J; Takaki H; Yamanaka T; Fujimori M; Hasegawa T; Sakuma H
    J Vasc Interv Radiol; 2016 Mar; 27(3):388-94. PubMed ID: 26723527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous radiofrequency ablation for pulmonary metastases from colorectal cancer: midterm results in 27 patients.
    Hiraki T; Gobara H; Iishi T; Sano Y; Iguchi T; Fujiwara H; Tajiri N; Sakurai J; Date H; Mimura H; Kanazawa S
    J Vasc Interv Radiol; 2007 Oct; 18(10):1264-9. PubMed ID: 17911517
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
    Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI
    Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor seeding following lung radiofrequency ablation: a case report.
    Yamakado K; Akeboshi M; Nakatsuka A; Takaki H; Takao M; Kobayashi H; Taguchi O; Takeda K
    Cardiovasc Intervent Radiol; 2005; 28(4):530-2. PubMed ID: 15983857
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
    Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT.
    Vogt FM; Antoch G; Veit P; Freudenberg LS; Blechschmid N; Diersch O; Bockisch A; Barkhausen J; Kuehl H
    J Nucl Med; 2007 Nov; 48(11):1836-44. PubMed ID: 17942811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device.
    Laganà D; Carrafiello G; Mangini M; Boni L; Dionigi G; Fusi MC; Cinquepalmi L; Rovera F; Cuffari S; Fugazzola C
    Surg Endosc; 2006 Aug; 20(8):1262-7. PubMed ID: 16858532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adrenal neoplasms: CT-guided radiofrequency ablation--preliminary results.
    Mayo-Smith WW; Dupuy DE
    Radiology; 2004 Apr; 231(1):225-30. PubMed ID: 14990812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathologic assessment of radiofrequency ablation of pulmonary metastases.
    Jaskolka JD; Kachura JR; Hwang DM; Tsao MS; Waddell TK; Asch MR; Darling GE; Johnston MR
    J Vasc Interv Radiol; 2010 Nov; 21(11):1689-96. PubMed ID: 20884239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution.
    Okuma T; Matsuoka T; Yamamoto A; Oyama Y; Hamamoto S; Toyoshima M; Nakamura K; Miki Y
    Cardiovasc Intervent Radiol; 2010 Aug; 33(4):787-93. PubMed ID: 19967367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe].
    Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M
    Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiofrequency ablation for liver metastasis from gastrointestinal stromal tumor.
    Yamanaka T; Takaki H; Nakatsuka A; Uraki J; Fujimori M; Hasegawa T; Sakuma H; Yamakado K
    J Vasc Interv Radiol; 2013 Mar; 24(3):341-6. PubMed ID: 23352855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiofrequency ablation of pulmonary lesions.
    Cariati M; Giordano G; Midulla M; Calati AM; Sacrini A; Raveglia F; Cornalba GP
    Radiol Med; 2007 Mar; 112(2):149-56. PubMed ID: 17361380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
    Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
    Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.
    Takaki H; Yamakado K; Nakatsuka A; Fuke H; Murata K; Shiraki K; Takeda K
    J Vasc Interv Radiol; 2007 Jul; 18(7):856-61. PubMed ID: 17609444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Maximum standardized uptake value is more reliable than size measurement in early follow-up to evaluate potential pulmonary malignancies following radiofrequency ablation.
    Alafate A; Shinya T; Okumura Y; Sato S; Hiraki T; Ishii H; Gobara H; Kato K; Fujiwara T; Miyoshi S; Kaji M; Kanazawa S
    Acta Med Okayama; 2013; 67(2):105-12. PubMed ID: 23603927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours.
    Rossi S; Dore R; Cascina A; Vespro V; Garbagnati F; Rosa L; Ravetta V; Azzaretti A; Di Tolla P; Orlandoni G; Pozzi E
    Eur Respir J; 2006 Mar; 27(3):556-63. PubMed ID: 16507856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oblique approach for CT-guided liver radiofrequency ablation using multiplanar reformation images in hepatocellular carcinoma.
    Kamei S; Matsuda J; Hagihara M; Kitagawa A; Izumi Y; Katsuda E; Oshima Y; Ikeda S; Kimura J; Ota T; Kawamura T; Ishiguchi T
    Jpn J Radiol; 2012 Jul; 30(6):533-9. PubMed ID: 22528338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.